LEFLUNOMIDE CH leflunomide 20mg tablet bottle

Active ingredient:

leflunomide, Quantity: 20 mg

Available from:

Southern Cross Pharma Pty Ltd

INN (International Name):

Leflunomide

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: magnesium stearate; crospovidone; maize starch; povidone; colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000

Administration route:

Oral

Units in package:

30 Tablet

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Treatment of active rheumatoid arthritis. The combined use of leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Product summary:

Visual Identification: Yellow, round biconvex tablets with a scoreline on one side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2014-04-02